| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,434,000 | 1,481,000 | 1,260,000 | 1,341,000 | | Cost of Revenue | 579,000 | 596,000 | 531,000 | 587,000 | | | Gross Profit | 855,000 | 885,000 | 729,000 | 754,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 502,000 | 550,000 | 499,000 | 493,000 | | Non Recurring | 52,000 | 10,000 | (62,000) | 1,068,000 | | Others | 29,000 | 28,000 | 27,000 | 29,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 272,000 | 297,000 | 265,000 | (836,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,000 | 3,000 | 4,000 | 12,000 | | Earnings Before Interest And Taxes | 293,000 | 300,000 | 269,000 | (824,000) | | Interest Expense | 51,000 | 52,000 | 55,000 | 58,000 | | Income Before Tax | 242,000 | 248,000 | 214,000 | (882,000) | | Income Tax Expense | 92,000 | 91,000 | 82,000 | (260,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 151,000 | 158,000 | 132,000 | (621,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 151,000 | 158,000 | 132,000 | (621,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $151,000 | $158,000 | $132,000 | ($621,000) |
|
0.47% Nasdaq 
0.20 (0.71%) 
Income Statement
